Platycoside A TN4804
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Platycoside A has hemolytic activity and adjuvant potential on the immune responses to Newcastle disease virus-based recombinant avian influenza vaccine. It induces the IgG and IgG1 antibody responses in the immunized mice.
CAS nr:
209404-00-2
Purity:
98%
Molecular Weight:
1255,4
SMILES:
C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@H](O)CO[C@@H]2OC(=O)[C@@]23CCC(C)(C)C[C@@H]2C2=CC[C@H]4[C@]5(C)C[C@@H](O)[C@@H](O[C@H]6O[C@@H](CO)[C@H](O)[C@@H](O[C@H]7O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]7O)[C@@H]6O)C(CO)(CO)[C@H]5CC[C@]4(C)[C@@]2(C)C[C@@H]3O)[C@@H](O)[C@@
Formula:
C58H94O29
Pathway:
Microbiology/Virology
Target:
Antifection
